Advanced Search


Study ID Status Title Patient Level Data
104147 Completed A multicentric, post-marketing surveillance to monitor the safety and reactogenicity of GlaxoSmithKline Biologicals Hepatitis A vaccine administered in Korean population.
104154 Completed Open, prospective study of the safety of GSK Biologicals' Boostrix® (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed) administered to a cohort of adolescents in a US Health Maintenance Organization (HMO)
104171 & 104730 Completed Pooled safety study of MenACWY vaccine given in subjects primed and boosted with investigational vaccination regimens and in subjects who received 4 doses of DTPw-HBV/Hib vaccine. Study Listed on
104228 Completed Post-marketing clinical study on PAXIL Tablet in patients with depression or depressive mood - A study on combination of PAXIL Tablet and benzodiazepines
104233 Completed A randomized, double-blinded, placebo-controlled, phase III study to evaluate the immunogenicity and safety of GSK Biologicals’ influenza vaccine (Fluarix™) administered intramuscularly in healthy adults
104243 Completed An observational study to Assess the Impact of Pharmacological Intervention and Life Style Changes in the Reduction of Cardiovascular Disease in patients with diabetes type 2 in Greece
104244 Completed A pharmacovigilance study to evaluate safety of AVODART (Dutasteride) administration 0,5 mg once daily, for 52 weeks, in subjects with benign prostate hyperplasia
104257 Completed A randomized, open-label, two period, period balanced, crossover study to estimate the relative bioavailability of an investigational drug compared to Coreg IR in healthy adult volunteers Study Listed on
104274 Completed A randomized, open-label, parallel-group study, to assess the pharmocodynamic effect on dihydrotestosterone regulated gene expression, longitudinally and in a dose dependent manner, of 0.5mg and 3.5mg dutasteride administered orally once daily, for one year in men with symptomatic benign prostatic hyperplasia and during a two month period between baseline and radical prostatectomy in men with biopsy-proven, clinically localized prostate cancer Study Listed on
104297 Completed An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Study Listed on
104298 Completed A Phase IIb randomized, double-blind, controlled study of the safety, immunogenicity and proof-of-concept of RTS,S/AS02D, a candidate malaria vaccine, when incorporated into an Expanded Program on Immunization (EPI) regimen that includes DTPw/Hib in infants living in a malaria-endemic region. Study Listed on
104326 Completed ARISTOTE Study: French cohort Study conducted to determine how ARIXTRA® 2.5 mg is used in every day practice, and to document the incidence of Venous Thromboembolic Events (VTEs) and major bleeding after orthopaedic surgery
104385 Completed A randomised double-blind two-period crossover study to investigate the effect of treatment with repeat doses of a PPAR gamma agonist on the allergen-induced late asthmatic response in subjects with mild asthma compared with repeat doses of placebo Study Listed on
104387 Completed Demonstrate the non-inferiority of immunogenicity elicited by GSK Biologicals’ hepatitis B vaccine, multidose Engerix™-B to that of monodose Engerix™-B when administered according to 0,1,6 mths schedule in healthy adults aged ≥ 18 yrs Study Listed on
104389 Completed Blinded, randomised, controlled study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ combined measles-mumps-rubella-varicella candidate vaccine given to healthy children in their second year of life Study Listed on
104420 Completed A phase II study to evaluate the persistence of measles, mumps and rubella antibodies two years after the single dose primary vaccination in study 209762/151. Study Listed on
104430 Completed Study to evaluate immunogenicity, reactogenicity and safety of an investigational vaccination regimen as compared to extemporaneously mixed GlaxoSmithKline Biological’s Hiberix and Tritanrix-HepB vaccines, when administered intramuscularly in infants at 6, 10 and 14 weeks of age Study Listed on
104435 Completed Post-Authorization Safety Study (PASS) of Post-Marketing Surveillance for Intussusception following Rotarix™ introduction into the Instituto Mexicano del Seguro Social (IMSS) in Mexico
104437 Completed A phase III, observer-blind, randomized study to evaluate the immunogenicity and safety of Fluarix™ (GlaxoSmithKline Biologicals) compared with Fluzone® (Aventis Pasteur) administered intramuscularly in adults 18 years and older in the U.S. Study Listed on
104438 Completed A randomized, double-blind, placebo-controlled, post-marketing phase III Study to evaluate the efficacy of GSK Biologicals’ influenza vaccine (Fluarix™) administered intramuscularly in adults. Study Listed on
104440-002 Completed Study in adults aged between 18 and 45 years to evaluate the reactogenicity and the immunogenicity of an experimental administration of GlaxoSmithKline Biologicals' Fluarix vaccine (known as a-Rix in Belgium). Standard intramuscular and subcutaneous vaccine administration will be used as references Study Listed on
104450 Completed This study is a non-randomized, open-label, multi-center Phase II study of GW786034 to evaluate the administration of oral GW786034 in subjects with ovarian cancer.
104479 Completed Phase IIIb, double-blind, randomized, controlled study to evaluate the immunogenicity and safety of GSK Biologicals’ HPV-16/18 VLP/AS04 vaccine administered intramuscularly at 0, 1, 6 months in healthy Indian female subjects aged 18–35 yrs Study Listed on
104480 Completed Compare the immunogenicity, reactogenicity & safety of 2 different formulations of GSK Biologicals’ live attenuated human rotavirus (HRV) vaccine given as a two-dose primary vaccination in healthy infants previously uninfected with HRV Study Listed on
104489 Terminated Study to assess immunogenicity and safety of GlaxoSmithKline Biologicals' Kft’s DTPw-HBV/Hib vs DTPwCSL-HBV/Hib Kft and vs concomitant administration of CSL’s Triple Antigen and GlaxoSmithKline Biologicals’ Hiberix, to infants at 2, 4, 6 months of age, after a birth dose of hepatitis B Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.